The intravenous anesthetic Propofol can inhibit the proliferation of HCC cells by activating the high mobility group AT-hook 2 (HMGA2) and Wnt/β-catenin signaling pathways (112). Here, HMGA2 is linked to hepatocellular carcinoma.